ACM
TCBPW

Altium Capital Management’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Altium Capital Management’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,823
Closed -$343 – 99
2024
Q3 		$343 Hold
18,823
– – ﹤0.01% 79
2024
Q2 		$235 Hold
18,823
– – ﹤0.01% 68
2024
Q1 		$376 Hold
18,823
– – ﹤0.01% 70
2023
Q4 		$612 Hold
18,823
– – ﹤0.01% 63
2023
Q3 		$393 Hold
18,823
– – ﹤0.01% 70
2023
Q2 		$809 Hold
18,823
– – ﹤0.01% 67
2023
Q1 		$1.88K Hold
18,823
– – ﹤0.01% 90
2022
Q4 		$1.68K Sell
18,823
-922,353
-98% -$127K ﹤0.01% 93
2022
Q3 		$118K Hold
941,176
– – 0.04% 106
2022
Q2 		$223K Hold
941,176
– – 0.09% 100
2022
Q1 		$461K Buy
+941,176
New +$438K 0.15% 91

Other funds holding TCBPW

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Altium Capital Management's TCBPW Position: Q4 2024 in Review

Altium Capital Management sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q4 2024, closing a stake of 18,823 shares — an estimated $343 sold.

Altium Capital Management first reported a position in TCBPW in Q1 2022 and held it in 11 quarters. The position peaked at $461K in Q1 2022. 6 funds tracked by Wall St. Rank hold TCBPW as of Q4 2024.

  • Altium Capital Management reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q4 2024 after selling out during the quarter.
  • Altium Capital Management sold 18,823 TC BioPharm (Holdings) plc Warrants shares in Q4 2024, an estimated $343.
  • Altium Capital Management first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and held it in 11 quarters.
  • Altium Capital Management's TC BioPharm (Holdings) plc Warrants position peaked at $461K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q4 2024.

Based on Altium Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.